Vertebroplasty and interventional radiology procedures for bone metastases

Autor: Laredo, Jean-Denis, Chiras, Jacques, Kemel, Salim, Taihi, Lokmane, Hamze, Bassam

Publikováno v: In Joint Bone Spine March 2018 85(2):191-199

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients

Autor: Mary, Aurélien, Hartemann, Agnes, Liabeuf, Sophie, Aubert, Carole Elodie, Kemel, Salim, Salem, Joe Elie, Cluzel, Philippe, Lenglet, Aurélie, Massy, Ziad A., Lalau, Jean-Daniel, Mentaverri, Romuald, Bourron, Olivier, Kamel, Saïd

Publikováno v: Cardiovascular Diabetology
Cardiovascular Diabetology, 2017, 16, ⟨10.1186/s12933-017-0509-7⟩
Mary, Aurélien; Hartemann, Agnes; Liabeuf, Sophie; Aubert, Carole Elodie; Kemel, Salim; Salem, Joe Elie; Cluzel, Philippe; Lenglet, Aurélie; Massy, Ziad A; Lalau, Jean-Daniel; Mentaverri, Romuald; Bourron, Olivier; Kamel, Saïd (2017). Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients. Cardiovascular diabetology, 16(1), p. 24. BioMed Central 10.1186/s12933-017-0509-7

International audience; Background: Vascular calcification (VC) is common in type 2 diabetes, and is associated with cardiovascular complications. Recent preclinical data suggest that metformin inhibits VC both in vitro and in animal models. However,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b6e3ecd88c7a2b5bb4da4e4b6b4406

Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.

Autor: Mary A; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France. aurelien.mary@u-picardie.fr.; Amiens University Medical Center, Pharmacy, 80054, Amiens, France. aurelien.mary@u-picardie.fr.; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France. aurelien.mary@u-picardie.fr., Hartemann A; Pitié Salpêtrière Hospital, Diabetology, 75005, Paris, France.; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; INSERM UMR_S 1138, Centre de recherche des Cordeliers, 75006, Paris, France.; Institute of Cardiometabolism and Nutrition, Paris, France., Liabeuf S; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France.; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France.; Amiens University Hospital, Clinical Research Centre, Division of Clinical Pharmacology, 80054, Amiens, France., Aubert CE; INSERM UMR_S 1138, Centre de recherche des Cordeliers, 75006, Paris, France.; Bern University Hospital, University of Bern, General Internal Medicine, 3012, Bern, Switzerland., Kemel S; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; Pitié Salpêtrière Hospital, Cardiovascular and Interventional Radiology, 75005, Paris, France.; FRANCE2Biomedical Imaging Lab, 75006, Paris, France., Salem JE; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; Institute of Cardiometabolism and Nutrition, Paris, France.; Pitié Salpêtrière Hospital, Pharmacology, 75005, Paris, France.; Pitié Salpêtrière Hospital, Clinical Investigation Center, CIC-1421, 75005, Paris, France., Cluzel P; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; Pitié Salpêtrière Hospital, Cardiovascular and Interventional Radiology, 75005, Paris, France.; FRANCE2Biomedical Imaging Lab, 75006, Paris, France., Lenglet A; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France.; Amiens University Medical Center, Pharmacy, 80054, Amiens, France.; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France., Massy ZA; Ambroise Paré Hospital, Nephrology, 92104, Boulogne-Billancourt, France.; Universite Versailles Saint-Quentin-en-Yvelines, Paris-Ile-de-France-Ouest, 78000, Versailles, France.; INSERM U-1018, Research Centre in Epidemiology and Population Health (CESP) Team 5, 94807, Villejuif, France., Lalau JD; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France.; Amiens University Medical Center, Endocrinology and Nutrition, 80054, Amiens, France.; Universite de Picardie Jules Verne, UFR Médecine, 80025, Amiens, France., Mentaverri R; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France.; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France.; Amiens University Hospital, Bone and Endocrine Biology, 80054, Amiens, France., Bourron O; Pitié Salpêtrière Hospital, Diabetology, 75005, Paris, France.; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; INSERM UMR_S 1138, Centre de recherche des Cordeliers, 75006, Paris, France.; Institute of Cardiometabolism and Nutrition, Paris, France., Kamel S; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France. said.kamel@u-picardie.fr.; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France. said.kamel@u-picardie.fr.; Amiens University Hospital, Biochemistry, 80054, Amiens, France. said.kamel@u-picardie.fr.

Publikováno v: Cardiovascular diabetology [Cardiovasc Diabetol] 2017 Feb 15; Vol. 16 (1), pp. 24. Date of Electronic Publication: 2017 Feb 15.